Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Modeling metazoan apoptotic pathways in yeast
Bloomer DT, Kitevska T, Brand IL, Jabbour AM, Nguyen H, Hawkins CJ
(2016), Methods Mol Biol, 1419,
Sprouty
Masoumi Moghaddam S, Amini A
(2016), In: Encyclopedia of Signaling Molecules, 2nd edition, Springer, USA,
Idarucizumab: an anticoagulant reversal agent for dabigatran
Brown AFT, Nandurkar H
(2016), Med Today, 17(11),
Editorial: the role of the plasminogen activating system in neurobiology
Medcalf RL, Lawrence DA
(2016), Front Cell Neurosci, 10,
Epigenetics in the biology and treatment of multiple myeloma
Spencer A, Mithraprabhu S
(2016), Eur Oncol Haematol, 12(2),
Plasminogen and stroke: more is better
Medcalf RL
(2016), J Thromb Haemost, 14(9),
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
Roboz GJ, Montesinos P, Selleslag D, Wei A, Jang JH, Falantes J, Voso MT, Sayar H, Porkka K, Marlton P, Almeida A, Mohan S, Ravandi F, Garcia-Manero G, Skikne B, Kantarjian H
(2016), Future Oncol, 12(3),
Protease-activated receptor 4: from structure to function and back again
French SL, Hamilton JR
(2016), Br J Pharmacol, 173(20),
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
Hocking J, Mithraprabhu S, Kalff A, Spencer A
(2016), Cancer Biol Med, 13(2),
LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19
Helsmoortel HH, De Moerloose B, Pieters T, Ghazavi F, Bresolin S, Cavé H, de Vries A, de Haas V, Flotho C, Labarque V, Niemeyer C, De Paepe P, Van Roy N, Stary J, van den Heuvel-Eibrink MM, Benoit Y, Schulte J, Goossens S, Berx G, Haigh JJ, Speleman F, Va
(2016), Haematologica, 101(6),
Highly sensitive detection of minimal cardiac ischemia using positron emission tomography imaging of activated platelets
Ziegler M, Alt K, Paterson BM, Kanellakis P, Bobik A, Donnelly PS, Hagemeyer CE, Peter K
(2016), Sci Rep, 6,
Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922)
Zheng Z, Pinson JA, Mountford SJ, Orive S, Schoenwaelder SM, Shackleford D, Powell A, Nelson EM, Hamilton JR, Jackson SP, Jennings IG, Thompson PE
(2016), Eur J Med Chem, 122,
Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling
Tremblay CS, Brown FC, Collett M, Saw J, Chiu SK, Sonderegger SE, Lucas SE, Alserihi R, Chau N, Toribio ML, McCormack MP, Chircop M, Robinson PJ, Jane SM, Curtis DJ
(2016), Leukemia, 30(10),
Fabrication of complex PDMS microfluidic structures and embedded functional substrates by one-step injection moulding
Szydzik C, Niego B, Dalzell G, Knoerzer M, Ball F, Nesbitt WS, Medcalf RL, Khoshmanesh K, Mitchell A
(2016), RSC Adv, 6(91),
Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains
Szabo R, Samson AL, Lawrence DA, Medcalf RL, Bugge TH
(2016), J Thromb Haemost, 14(8),
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: results from a phase 1 study
Swords RT, Greenberg PL, Wei AH, Durrant S, Advani AS, Hertzberg MS, Lewis ID, Rivera G, Gratzinger D, Fan AC, Felsher DW, Cortes JE, Watts JM, Yarranton GT, Walling JM, Lancet JE
(2016), Leuk Res, 50,
The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2
Scott CL, Soen B, Martens L, Skrypek N, Saelens W, Taminau J, Blancke G, Van Isterdael G, Huylebroeck D, Haigh J, Saeys Y, Guilliams M, Lambrecht BN, Berx G
(2016), J Exp Med, 213(6),
The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells
Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F
(2016), Leukemia, 30(1),
Physicochemical properties that control protein aggregation also determine whether a protein is retained or released from necrotic cells
Samson AL, Ho B, Au AE, Schoenwaelder SM, Smyth MJ, Bottomley SP, Kleifeld O, Medcalf RL
(2016), Open Biol, 6(11),
Polymer capsules for plaque-targeted in vivo delivery
Richardson JJ, Choy MY, Guo J, Liang K, Alt K, Ping Y, Cui J, Law LS, Hagemeyer CE, Caruso F
(2016), Adv Mater, 28(36),